| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |